Safety and availability of clofazimine in the treatment of multidrug and extensively drug-resistant tuberculosis: analysis of published guidance and meta-analysis of cohort studies

OBJECTIVES: Given the spread of multidrug-resistant tuberculosis (MDR-TB), new therapies are urgently needed, including the repurposing of existing drugs. We aimed to assess key considerations for the clinical and programmatic use of clofazimine (Cfz), a riminophenazine with antimycobacterial activi...

Descripción completa

Detalles Bibliográficos
Autores principales: Hwang, Thomas J, Dotsenko, Svetlana, Jafarov, Azizkhon, Weyer, Karin, Falzon, Dennis, Lunte, Kaspars, Nunn, Paul, Jaramillo, Ernesto, Keshavjee, Salmaan, Wares, Douglas F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2014
Materias:
Global Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3902362/
https://www.ncbi.nlm.nih.gov/pubmed/24384902
http://dx.doi.org/10.1136/bmjopen-2013-004143

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3902362/
https://www.ncbi.nlm.nih.gov/pubmed/24384902
http://dx.doi.org/10.1136/bmjopen-2013-004143

Ejemplares similares